“GV 2019 GP, L.P., its General Partner”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  2/29/24  as  ↓Signatory

        

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“GV 2019 GP, L.P., its General Partner” has been a Signatory for/with  15  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/29/24		CA	GV 2019, L.P.	4	SC 13G/A	MA	Prime Medicine, Inc.
2/28/24		NY	Schrodinger, Inc.	1	10-K	—
12/11/23		CA	GV 2017, L.P.	4	SC 13G/A	MA	Verve Therapeutics, Inc.
2/14/22		CA	GV 2016, L.P.	4	SC 13G	MD	IonQ, Inc.
1/12/22		MA	Prime Medicine, Inc.	1	DRS/A	—
10/4/21		MD	IonQ, Inc.	1	8-K	—
6/30/21		MA	Desktop Metal, Inc.	1	S-1	—
5/28/21		MA	Verve Therapeutics, Inc.	2	S-1	—
2/11/21		CA	GV 2019 GP, L.L.C.	1	3	MA	Decibel Therapeutics, Inc.
2/11/21		CA	GV 2019 GP, L.P.	1	3	MA	Decibel Therapeutics, Inc.
1/22/21		MA	Decibel Therapeutics, Inc.	2	S-1	—
1/12/21		WA	Sana Biotechnology, Inc.	2	S-1	—
9/18/20		CA	Kronos Bio, Inc.	2	S-1	—
9/9/20		CA	Grail, LLC	2	S-1	—
9/2/20		TX	Taysha Gene Therapies, Inc.	1	S-1	—

“GV 2019 GP, L.P., its General Partner” has/had a Signatory interest in  9  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/29/24		MA	Prime Medicine, Inc.	1	SC 13G/A	CA	GV 2019, L.P.
12/11/23		MA	Verve Therapeutics, Inc.	2	SC 13G/A	CA	GV 2017, L.P.
2/14/22		MO	Benson Hill, Inc.	1	SC 13G	CA	GV 2017, L.P.
2/14/22		MA	EQRx, Inc.	1	SC 13G	CA	GV 2019, L.P.
2/14/22		MD	IonQ, Inc.	2	SC 13G	CA	GV 2016, L.P.
2/14/22		MA	Invivyd, Inc.	1	SC 13G	CA	GV 2019, L.P.
2/14/22		MA	Decibel Therapeutics, Inc.	2	SC 13G	CA	GV 2016, L.P.
2/14/22		MA	TScan Therapeutics, Inc.	1	SC 13G	CA	GV 2017, L.P.
2/10/21		MA	Desktop Metal, Inc.	1	SC 13G	CA	GV 2016, L.P.